4.7 Article

Brush swab as a noninvasive surrogate for tissue biopsies in epigenomic profiling of oral cancer

期刊

BIOMARKER RESEARCH
卷 9, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s40364-021-00349-x

关键词

Methylation biomarker; Oral cancer; Head and neck cancer; Epigenetic biomarker; Brush swab; Brush biopsy; Biomarker; MethylCap-Seq; Methylation array

资金

  1. National Institute on Drug Abuse [R01DA047063, R01DA047820]
  2. National Institute of Dental and Craniofacial Research [K23DE030250]
  3. Oral Maxillofacial Surgery Foundation

向作者/读者索取更多资源

This study utilized MethylCap-Seq technique along with brush swab samples to develop a non-invasive methylation profiling method in oral squamous cell carcinoma patients. The results demonstrated that brush swab samples provide adequate DNA yield and methylation resolution comparable to tissue samples, indicating a promising approach for methylome studies in OSCC patients.
Background Oral squamous cell carcinoma (OSCC) has poor survival rates. There is a pressing need to develop more precise risk assessment methods to tailor clinical treatment. Epigenome-wide association studies in OSCC have not produced a viable biomarker. These studies have relied on methylation array platforms, which are limited in their ability to profile the methylome. In this study, we use MethylCap-Seq (MC-Seq), a comprehensive methylation quantification technique, and brush swab samples, to develop a noninvasive, readily translatable approach to profile the methylome in OSCC patients. Methods Three OSCC patients underwent collection of cancer and contralateral normal tissue and brush swab biopsies, totaling 4 samples for each patient. Epigenome-wide DNA methylation quantification was performed using the SureSelectXT Methyl-Seq platform. DNA quality and methylation site resolution were compared between brush swab and tissue samples. Correlation and methylation value difference were determined for brush swabs vs. tissues for each respective patient and site (i.e., cancer or normal). Correlations were calculated between cancer and normal tissues and brush swab samples for each patient to determine the robustness of DNA methylation marks using brush swabs in clinical biomarker studies. Results There were no significant differences in DNA yield between tissue and brush swab samples. Mapping efficiency exceeded 90% across all samples, with no differences between tissue and brush swabs. The average number of CpG sites with at least 10x depth of coverage was 2,716,674 for brush swabs and 2,903,261 for tissues. Matched tissue and brush swabs had excellent correlation (r = 0.913 for cancer samples and r = 0.951 for normal samples). The methylation profile of the top 1000 CpGs was significantly different between cancer and normal samples (mean p-value = 0.00021) but not different between tissues and brush swabs (mean p-value = 0.11). Conclusions Our results demonstrate that MC-Seq is an efficient platform for epigenome profiling in cancer biomarker studies, with broader methylome coverage than array-based platforms. Brush swab biopsy provides adequate DNA yield for MC-Seq, and taken together, our findings set the stage for development of a non-invasive methylome quantification technique for oral cancer with high translational potential.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据